Cialis (tadalafil) increases blood flow throughout the body, and that effect is not sex-specific. When a woman takes it, the drug works on the same enzyme system it targets in men, relaxing smooth muscle in blood vessel walls and boosting circulation to various tissues, including genital tissue. But whether that physical blood-flow boost translates into a meaningful improvement in sexual experience for women is a question researchers have spent years trying to answer, with results that are more complicated than the pharmacology alone would suggest.
How Tadalafil Works in a Woman’s Body
Tadalafil belongs to a class of drugs called PDE5 inhibitors. PDE5 is an enzyme found in smooth muscle tissue lining blood vessels. When tadalafil blocks that enzyme, blood vessels relax and widen, allowing more blood to flow through. In men, the most obvious downstream effect is improved erections. In women, the same vasodilation occurs in clitoral and vaginal tissue, increasing what researchers call genital vasocongestion, essentially engorgement and lubrication driven by blood flow.
The physiology here is straightforward. Studies that measured the physical response of genital tissue to PDE5 inhibitors consistently found significant increases in blood flow and engorgement in women. The disconnect shows up when you ask women whether they actually felt more aroused or satisfied. Research using self-reported measures of sexual functioning showed mixed results, even when the measurable physiological response was clearly there.1PubMed Central. Phosphodiesterase type 5 inhibitors and female sexual response: faulty protocols or paradigms? In other words, tadalafil reliably sends more blood to the right places in women, but that does not automatically mean a woman feels more turned on or enjoys sex more.
Why Cialis Was Never Approved for Female Sexual Dysfunction
Eli Lilly, the company behind Cialis, ran a large, multisite Phase III clinical trial testing tadalafil specifically for female sexual arousal disorder.2PubMed Central. Behavior and Symptom Change Among Women Treated with Placebo for Sexual Dysfunction Phase III trials are the final stage before a company can seek regulatory approval, so this was a serious, well-funded effort. The trial did not produce the results the company needed. Tadalafil failed to show a clear, consistent advantage over placebo in the outcomes that mattered most to the women in the study, things like desire, satisfaction, and distress about their sexual experiences.
One reason for this is that female sexual arousal is less mechanically driven than male arousal. An erection is a largely vascular event. It either happens or it doesn’t, and a blood-flow drug can make a measurable difference. Female arousal involves blood flow too, but the subjective experience of arousal, the feeling of wanting and enjoying sex, depends heavily on psychological, relational, and hormonal factors that a vasodilator cannot touch. A woman can have increased genital blood flow and still not feel aroused in any way she’d describe as meaningful.
Another complicating factor was the surprisingly strong placebo response. Women in the placebo group of the tadalafil trial also reported improvements in sexual function, simply from the experience of being in a clinical trial, receiving attention for their sexual health, and expecting a treatment to work.2PubMed Central. Behavior and Symptom Change Among Women Treated with Placebo for Sexual Dysfunction That high placebo response made it nearly impossible for tadalafil to demonstrate a statistically meaningful edge, even if it was producing a real physiological effect. Some researchers have argued that the problem was less about the drug failing and more about how the trials were designed, suggesting that the standard clinical-trial framework built around male sexual dysfunction was a poor fit for studying female sexual response.1PubMed Central. Phosphodiesterase type 5 inhibitors and female sexual response: faulty protocols or paradigms?
Side Effects Women Should Expect
Tadalafil produces the same general side effects in women as in men: headache, flushing, nasal congestion, indigestion, and muscle or back pain. These happen because the drug dilates blood vessels throughout the body, not just in one area. The headache, for instance, comes from widened blood vessels in the head. Flushing is the same mechanism playing out in the skin.
There is evidence that women may experience these side effects more intensely than men. A randomized clinical trial testing tadalafil for cerebral small vessel disease found that female participants were more prone than male participants to experience the known tadalafil side effects, including headaches and muscle, back, and eye pain.3American Heart Association Journals. Tadalafil Treatment in Patients With Cerebral Small Vessel Disease: The ETLAS-2 Randomized Clinical Trial The reasons for this sex difference aren’t entirely clear, but differences in body weight, body composition, and hormonal environment likely play a role. A standard dose of tadalafil results in higher blood concentrations in a smaller person, and women on average weigh less than men.
Most of these side effects are mild and temporary, resolving within a few hours as the drug clears the system. Tadalafil has a notably long half-life compared to other PDE5 inhibitors (it stays active in the body for up to 36 hours), so side effects can linger longer than with a shorter-acting drug like sildenafil.
Serious Risks and Drug Interactions
The most dangerous risk with tadalafil, regardless of the patient’s sex, is a sudden and severe drop in blood pressure. This is especially true for anyone taking nitrate medications, which are prescribed for chest pain and certain heart conditions. The FDA label for Cialis explicitly warns that the drug can amplify the blood-pressure-lowering effects of nitrates, alpha-blockers, other antihypertensives, and alcohol.4U.S. Food and Drug Administration. CIALIS (tadalafil) Tablet, Film Coated for Oral use The combination of tadalafil with a nitrate can cause blood pressure to plummet to dangerous levels, potentially leading to fainting, stroke, or heart attack.
This interaction is not theoretical. It is a well-documented pharmacological effect and the reason doctors screen for nitrate use before prescribing any PDE5 inhibitor. Women who take nitroglycerin for angina or recreational drugs like amyl nitrite (“poppers”) face the same lethal risk as men. The warning extends to alpha-blockers, which some women take for conditions like kidney stones or off-label for urinary issues, and to common blood pressure medications.
Alcohol compounds the risk because it is also a vasodilator. A woman who takes tadalafil and then drinks heavily could experience dizziness, lightheadedness, or fainting from the combined blood-pressure drop. The FDA label’s warning about alcohol applies equally to both sexes.4U.S. Food and Drug Administration. CIALIS (tadalafil) Tablet, Film Coated for Oral use
A rarer but serious risk is a sudden decrease in vision or hearing. These events have been reported with all PDE5 inhibitors and, while uncommon, require immediate medical attention. There is also a theoretical concern about priapism-like prolonged engorgement of clitoral tissue, though reports of this in women are exceedingly rare in the medical literature.
When Women Are Already Prescribed Tadalafil
Despite not being approved for female sexual dysfunction, tadalafil is already prescribed to women for other conditions. The most common is pulmonary arterial hypertension, a serious condition where blood pressure in the arteries of the lungs is dangerously high. In this context, tadalafil is marketed under the brand name Adcirca rather than Cialis, but the active ingredient is identical. A major placebo-controlled trial found that tadalafil at 40 mg improved exercise capacity and delayed clinical worsening in patients with pulmonary arterial hypertension.5PubMed Central. Tadalafil for the treatment of pulmonary arterial hypertension: a double-blind 52-week uncontrolled extension study Pulmonary arterial hypertension disproportionately affects women, so a large share of the patients on tadalafil for this condition are female.
The dose for pulmonary hypertension (40 mg daily) is higher than the typical dose used for erectile dysfunction (10 or 20 mg as needed), and it is taken every day rather than before sexual activity. Women on this regimen are monitored by their doctors and generally tolerate the drug well over the long term, though the side effect profile, particularly headache and flushing, remains consistent with what is seen at lower doses.
Off-Label Uses That Affect Women
Because tadalafil’s core action is improving blood flow, doctors sometimes prescribe it off-label for conditions that involve impaired circulation. One notable example is Raynaud’s phenomenon, a condition where blood vessels in the fingers and toes constrict excessively in response to cold or stress, causing painful episodes of numbness, color changes, and sometimes tissue damage. Raynaud’s is far more common in women than in men.
A systematic review and network meta-analysis found that PDE5 inhibitors were more effective than placebo at reducing the frequency, severity, and duration of Raynaud’s attacks.6The Lancet Rheumatology. Comparative efficacy and safety of pharmacological treatments in secondary Raynaud’s phenomenon: a systematic review and network meta-analysis The evidence was rated low to moderate, which means the effect is real but its precise size is still uncertain. For women with secondary Raynaud’s (the type linked to autoimmune conditions like scleroderma), tadalafil can be a meaningful treatment option when first-line drugs like calcium channel blockers are not enough.
Other off-label uses being explored include tadalafil for female athletes at high altitude, where improved pulmonary blood flow could help with acclimatization, and for certain types of bladder dysfunction. These uses are still in the early research stages and are not standard clinical practice.
The Gap Between Physiology and Desire
The story of Cialis and women comes back to a fundamental mismatch between what the drug does and what many women experiencing sexual difficulties actually need. Tadalafil is excellent at increasing blood flow. For conditions that are fundamentally about blood flow, like pulmonary hypertension and Raynaud’s, it works well in women. For sexual dysfunction, the picture is murkier because the problem is often not a lack of blood flow in the first place.
Female sexual dysfunction encompasses a wide range of issues: low desire, difficulty with arousal, pain during intercourse, inability to reach orgasm. Only a subset of these are plausibly related to genital blood flow. A woman whose primary complaint is low desire will not find that tadalafil creates desire where none exists. A woman with pain during sex due to vaginal atrophy or pelvic floor dysfunction needs a different intervention entirely. The research bears this out: tadalafil changes what can be measured with a device in a lab but does not reliably change what women report about their sexual lives.1PubMed Central. Phosphodiesterase type 5 inhibitors and female sexual response: faulty protocols or paradigms?
This does not mean no woman would ever benefit from tadalafil for sexual purposes. Some women with specific arousal difficulties related to blood flow, such as those caused by antidepressant side effects, diabetes-related vascular changes, or post-menopausal changes in genital tissue, might notice a difference. But these are narrow populations, and the evidence base for these specific subgroups is thin. A doctor willing to prescribe tadalafil off-label for a woman’s sexual health concern would be doing so based on clinical judgment rather than strong trial data.
Why Women Sometimes Take Cialis Without a Prescription
Tadalafil is easy to obtain online, and some women experiment with it after hearing anecdotal reports that it enhances sexual sensation. The internet is full of personal testimonials claiming the drug increased clitoral sensitivity, made orgasms easier to achieve, or improved lubrication. These reports are not fabricated: they align with what the physiology would predict, since increased blood flow to genital tissue genuinely does enhance engorgement and sensitivity for some individuals.
The problem is that anecdotal reports are heavily shaped by expectation. A woman who takes a pill she believes will enhance her sexual experience is already primed to notice any change and attribute it to the drug. This is exactly the dynamic that made the placebo group in the clinical trial report improvements too.2PubMed Central. Behavior and Symptom Change Among Women Treated with Placebo for Sexual Dysfunction That does not mean every positive report is placebo effect, but it makes it impossible to know from casual experience whether the drug is doing the heavy lifting or the expectation is.
Self-prescribing also carries real risk. Without a doctor’s involvement, a woman might not know she is taking a medication that interacts dangerously with tadalafil. The nitrate interaction is the most serious, but even common over-the-counter medications and supplements can alter how the drug is metabolized. Grapefruit juice, for instance, inhibits the liver enzyme that breaks down tadalafil, potentially increasing blood levels of the drug and intensifying side effects. Women with undiagnosed heart conditions, low blood pressure, or liver problems face additional risks they might not anticipate.
How Dosing Differs When Women Use Tadalafil
There is no FDA-approved dose of tadalafil for female sexual dysfunction, so when doctors do prescribe it off-label for this purpose, they tend to start lower than the standard male erectile dysfunction dose. A common approach is 5 mg or 10 mg, since women generally have lower body weight and may be more sensitive to the blood-pressure-lowering effects. For pulmonary arterial hypertension, however, the dose is a flat 40 mg daily regardless of sex, reflecting the severity of the condition and the higher drug levels needed to affect the pulmonary vasculature.5PubMed Central. Tadalafil for the treatment of pulmonary arterial hypertension: a double-blind 52-week uncontrolled extension study
For Raynaud’s, dosing is similarly variable and based on clinical judgment rather than firm guidelines, since the use is off-label. Some providers start at 10 mg daily and titrate up based on response and tolerability. The finding that women may experience more pronounced side effects than men suggests that a cautious, lower starting dose is sensible regardless of the indication.3American Heart Association Journals. Tadalafil Treatment in Patients With Cerebral Small Vessel Disease: The ETLAS-2 Randomized Clinical Trial
Pregnancy, Breastfeeding, and Fertility Considerations
Tadalafil has not been well studied in pregnant or breastfeeding women. The FDA label does not recommend its use during pregnancy, and animal studies at very high doses showed some effects on fetal development, though it is unclear how relevant those findings are at human therapeutic doses. Women who are pregnant or planning to become pregnant should avoid tadalafil unless specifically directed by a physician managing a condition like pulmonary hypertension, where the risk of untreated disease may outweigh the uncertain drug risk.
There is some early-stage research interest in whether PDE5 inhibitors could improve uterine blood flow in women undergoing fertility treatments or those with recurrent implantation failure. Some fertility clinics have experimented with vaginal sildenafil (a related PDE5 inhibitor) to improve endometrial thickness. Tadalafil’s longer duration of action makes it theoretically appealing for this purpose, but the evidence is preliminary and this use remains firmly experimental. Whether the drug passes into breast milk in clinically meaningful amounts is unknown, so breastfeeding women are generally advised to avoid it as a precaution.